Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The biopharmaceutical contract manufacturing market is projected to reach $6.3 billion in 2020, and it will continue to grow over the next five years.
November 17, 2020
By: William downey
President, HighTech Business Decisions
The biopharmaceutical contract manufacturing market continues its upward trajectory as pharmaceutical and biotechnology companies increase their spending for outsourced services. This growth results from the expanded use of biopharmaceuticals, new biopharmaceutical approvals and new biopharmaceutical development programs. This article reviews the biopharmaceutical contract manufacturing market, capacity utilization and additions, outsourcing decision factors, and selected industry trends. The information presented in this article draws from HighTech Business Decisions’ latest report, “Biopharmaceutical Contract Manufacturing 2020: New Demand and Expanded Services.”1 This report is based on primary research from senior-level executives and scientists at pharmaceutical and biotechnology companies plus executives at contract manufacturing organizations. For purposes of our article, HighTech Business Decisions defines biopharmaceuticals as complex molecules expressed through the genetically manipulated living cells or organisms used for therapeutics or vaccines. Market growth The biopharmaceutical contract manufacturing market will reach $6.3 billion in 2020. The market will continue to grow as pharmaceutical and biotechnology companies increase their spending for outsourced services. The expected increase in outsourced spending is consistent with the biopharmaceutical contract manufacturing organizations’ expectations. The biopharmaceutical contract manufacturing organizations (CMOs) expect double-digit market growth over the next three years, with smaller CMOs expecting higher growth rates compared to larger CMOs. The CMOs gave several reasons for their optimistic outlook. These reasons include an increase in small, well-funded virtual biotechnology companies, higher demand for production services supporting cell and gene therapies, and higher growth in Asia. The market to support cell and gene therapies is expected to grow at twice the overall industry growth rate. Over the next few years, monoclonal antibodies (mAbs) will account for half the molecules entering the clinical pipeline, including standard mAbs and multi-specific mAbs. Molecules related to cell and gene therapies, including viral vectors, will account for 23% of the molecules entering the clinical pipeline. All CMOs offer production, development and ancillary services. Overall, production accounts for 80% of the market. Development and ancillary services (e.g., testing, cell banking, and regulatory support) account for roughly 20% of the market. The mix between production and all other services has remained steady over the past several years. Below are selected comments from CMOs regarding the demand for biopharmaceutical contract manufacturing:
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !